Lumos Diagnostics Holdings Limited
LDXHF
$0.015
$0.000.00%
| Weiss Ratings | LDXHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | LDXHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | LDXHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Price History | LDXHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 11.11% | |||
| 30-Day Total Return | -66.52% | |||
| 60-Day Total Return | -45.45% | |||
| 90-Day Total Return | -27.18% | |||
| Year to Date Total Return | -50.00% | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -95.50% | |||
| 52-Week Low % Change | 11.11% | |||
| Price | LDXHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.33 | |||
| 52-Week Low Price | $0.01 | |||
| 52-Week Low Price (Date) | Mar 05, 2025 | |||
| 52-Week High Price (Date) | Sep 06, 2024 | |||
| Valuation | LDXHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 9.92M | |||
| Enterprise Value | 12.24M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.01 | |||
| Earnings Per Share Growth | -61.02% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.63 | |||
| Price/Book (Q) | 1.15 | |||
| Enterprise Value/Revenue (TTM) | 0.83 | |||
| Price | $0.02 | |||
| Enterprise Value/EBITDA (TTM) | -3.33 | |||
| Enterprise Value/EBIT | -2.22 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | LDXHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 612.96M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | LDXHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 855 586 6739 | |||
| Address | 2724 Loker Ave West Carlsbad, CA 92010 | |||
| Website | lumosdiagnostics.com | |||
| Country | United States | |||
| Year Founded | 2018 | |||
| Profitability | LDXHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -37.45% | |||
| Profit Margin | -33.96% | |||
| Management Effectiveness | LDXHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -13.86% | |||
| Return on Equity | -- | |||
| Income Statement | LDXHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 14.67M | |||
| Total Revenue (TTM) | 14.67M | |||
| Revenue Per Share | $0.02 | |||
| Gross Profit (TTM) | 9.37M | |||
| EBITDA (TTM) | -3.66M | |||
| EBIT (TTM) | -5.50M | |||
| Net Income (TTM) | -4.98M | |||
| Net Income Avl. to Common (TTM) | -4.98M | |||
| Total Revenue Growth (Q YOY) | 127.98% | |||
| Earnings Growth (Q YOY) | 56.28% | |||
| EPS Diluted (TTM) | -0.01 | |||
| EPS Diluted Growth (Q YOY) | 68.06% | |||
| Balance Sheet | LDXHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 5.53M | |||
| Cash Per Share (Q) | $0.01 | |||
| Total Current Assets (Q) | 10.97M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 9.79M | |||
| Current Ratio (Q) | 1.104 | |||
| Book Value Per Share (Q) | $0.01 | |||
| Total Assets (Q) | 26.49M | |||
| Total Current Liabilities (Q) | 9.94M | |||
| Total Debt (Q) | 7.81M | |||
| Total Liabilities (Q) | 16.70M | |||
| Total Common Equity (Q) | 9.79M | |||
| Cash Flow | LDXHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -97.00K | |||
| Cash from Financing (TTM) | 5.20M | |||
| Net Change in Cash (TTM) | 4.15M | |||
| Levered Free Cash Flow (TTM) | 1.00M | |||
| Cash from Operations (TTM) | -529.00K | |||
